Search - tctmd.com

Displaying 1 - 6 of 6

Sort: Relevancy | Date

RIBS IV: 3-Year Outcomes From a Randomized Trial of a Metallic DES vs a Drug-Eluting Balloon in Patients With DES Restenosis

Presentation TCT 2017

RIBS IV: 3-Year Outcomes From a Randomized Trial of a Metallic DES vs a Drug-Eluting Balloon in Patients With DES Restenosis

Presenter: Thomas F. Luscher, Fernando Alfonso

October 31, 2017

ILUMIEN III: 1-Year Outcomes From a Randomized Trial of OCT-Guided vs IVUS-Guided vs Angiography-Guided Stent Implantation

Presentation TCT 2017

ILUMIEN III: 1-Year Outcomes From a Randomized Trial of OCT-Guided vs IVUS-Guided vs Angiography-Guided Stent Implantation

Presenter: Thomas F. Luscher, Ziad A. Ali

October 31, 2017

ABSORB PSP: Impact of Technique on Early and Late Outcomes Following Coronary Bioresorbable Scaffold Implantation

Presentation TCT 2017

ABSORB PSP: Impact of Technique on Early and Late Outcomes Following Coronary Bioresorbable Scaffold Implantation

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Gregg W. Stone

October 31, 2017

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

Presentation TCT 2017

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

Presenter: Peter C. Block, Lars Sondergaard, Daniel J. Blackman

October 31, 2017

ABSORB 3-Year Meta-analysis: 3-Year Outcomes of a Bioresorbable Scaffold Compared to a Metallic DES From an Individual Patient Data Meta-analysis of Four Randomized Trials

Presentation TCT 2017

ABSORB 3-Year Meta-analysis: 3-Year Outcomes of a Bioresorbable Scaffold Compared to a Metallic DES From an Individual Patient Data Meta-analysis of Four Randomized Trials

Presenter: David P. Faxon, Joseph A. Hill, Ziad A. Ali

October 31, 2017

Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk

Presentation ACC 2017

Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk

Presenter: Marc Sabatine

March 17, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.